---
$id: https://graph.org.ai/products/commodity/51171934
$type: Product
source: UNSPSC
code: "51171934"
title: "Deboxamet"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Deboxamet

**UNSPSC Code**: 51171934
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-ulcer agent with the molecular formula C12H14N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QJH0XA6AW9, chemically known as 1h-indole-3-acetamide, n-hydroxy-5-methoxy-2-methyl- but generally known as deboxamet, which bears US NIH Compound Identifier 36660. European Medicines Agency schedules Deboxamet in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06927MIG. The term DEBOXAMET is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). DEBOXAMET is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule deboxamet under HS 29339990 and SITC 51577. As of Q4 2014, DEBOXAMET remains the US FDA Preferred Term for this commodity. Deboxamet bears US NLM identifiers UMLS ID C0636219 and NCI Concept Code C76483. SMILES: CC1=C(C2=C(N1)C=CC(=C2)OC)CC(=O)NO.

